DOI QR코드

DOI QR Code

Rhabdomyolysis induced by venomous snake bite

독사 교상 후 발생하는 횡문근 융해증

  • Jungho Lee (Department of Emergency Medicine, Chonnam National University Hospital) ;
  • Jeongmi Moon (Department of Emergency Medicine, Chonnam National University Hwasun Hospital) ;
  • Byeongjo Chun (Department of Emergency Medicine, Chonnam National University Hospital)
  • 이정호 (전남대학교병원 응급의학과) ;
  • 문정미 (화순전남대학교병원 응급의학과) ;
  • 전병조 (전남대학교병원 응급의학과)
  • Received : 2022.08.02
  • Accepted : 2022.10.07
  • Published : 2022.12.31

Abstract

Purpose: Despite previous studies reporting the development of rhabdomyolysis (RM), this affliction tends to be neglected as an envenomation sign in South Korea. The current retrospective study investigates the prevalence and prognosis of RM after a snakebite. We further searched for predictors of snakebite-induced RM, which can be observed at presentation. Methods: This study included 231 patients who presented to the ED within 24 hours after a snakebite. The patients were classified according to the severity of RM, and the data, comprising baseline characteristics and clinical course including the level of creatine kinase (CK), were collected and compared according to the severity of RM. Results: The prevalence of RM and severe RM were determined to be 39% and 18.5%, respectively. Compared to the group without RM or with mild RM, the group with severe RM had a higher grade of local swelling, a higher frequency of acute kidney injury and neurotoxicity, and a greater need for renal replacement therapy and vasopressor administration. However, the incidence of acute renal injury in the RM group was 7.7%, with two patients needing renal replacement therapy. No mortalities were reported at discharge. Results of the multinomial logistic regression model revealed that the WBC levels are significantly associated with the risk of severe RM. Conclusion: RM should be considered the primary clinical sign of snake envenomation in South Korea, although it does not seem to worsen the clinical course. In particular, physicians should pay attention to patients who present with leukocytosis after a snakebite, which indicates the risk of developing RM, regardless of the CK level at presentation.

Keywords

Acknowledgement

재정적 지원: 이 성과는 정부(과학기술정보통신부)의 재원으로 한국연구재단의 지원을 받아 수행된 연구임 (NRF-2022R1A2C2013209) 이 논문은 대한임상독성학회지와 다른 학회지에 동시에 투고되지 않았으며 이전에 다른 학회지에 게재된 적이 없습니다.

References

  1. Available at https://www.who.int/docs/default-source/searo/india/health-topic-pdf/who-guidance-on-management-of-snakebites.pdf?sfvrsn=5528d0cf_2. Accessed at July 28, 2022.
  2. Lim H, Kang HG, Kim KH. Antivenom for snake bite in Korea. J Korea Med Assoc 2013;56(12):1091-103. https://doi.org/10.5124/jkma.2013.56.12.1091
  3. Kang SH, Moon JM, Chun BJ. Does the traditional snakebite severity score correctly classify the envenomated patients with snake? Clin Exp Emerg Med. 2016;3(1):34-40. https://doi.org/10.15441/ceem.16.123
  4. Shim JH, Son YJ, Lee SS, Park KS, Oh HB, Park YD. Ecological study on poisonous snake and investigation of the venom characteristics, snakebiting frequency in korea. Korean J Environ Ecol 1998;12:58-77.
  5. Williams HF, Layfield HJ, Vallance T, Patel K, Bicknell A, Trim SA, et al. The urgent need to develop novel strategies for the diagnosis and treatment of snakebites. Toxins 2019;11:363
  6. Moon JM, Koo YJ, Chun BJ, Park KH, Cho YS, Kim JC, et al. The effect of myocardial injury on the clinical course of snake envenomation in South Korea. Clin Toxicol (Phila) 2021;59(4):286-95. https://doi.org/10.1080/15563650.2020.1802473
  7. Cha YS, Lee KH, Lee SJ, Kwon HC, Lee JW, Kim HI, et al. Usefulness of delta neutrophil index for early prediction of overt disseminated intravascular coagulopathy in patients with venomous snakebite. Clin Exp Emerg Med 2018;5(2):76-83. https://doi.org/10.15441/ceem.16.195
  8. Park KH, Shin H, Kang H, Kim C, Choi HJ, Yoo K, et al. Effectiveness of repeated antivenom therapy for snakebite related systemic complications. J Int Med Res 2019;47(10):4808-14 https://doi.org/10.1177/0300060519870012
  9. Long B, Koyfman A, Gottlieb M. An evidence-based narrative review of the emergency department evaluation and management of rhabdomyolysis. Am J Emerg Med 2019;37(3):518-23. https://doi.org/10.1016/j.ajem.2018.12.061
  10. Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJA, de Visser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord, 2014;24:651-9.
  11. Torres PA, Helmstetter JA, Kaye AM. Rhabdomyolysis: Pathogenesis, diagnosis, and treatment. Ochsner J 2015;15:58-69.
  12. Gupta A, Thorson P, Penmatsa KR, Gupta P. Rhabdomyolysis: Revisited. Ulster Med J 2021;90(2):61-6
  13. Jeon YJ, Kim WJ, Park SG, Shin DW. Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study. Acute Crit Care 2019;34:269-75. https://doi.org/10.4266/acc.2019.00591
  14. Park EJ, Yoon SK, Ahn JH, Choi SC, Kim GW, Min YG, et al. Systemic complications occurring after korean venomous snake bite with focus on hematologic and neurologic complications. J Korean Soc Clin Toxicol 2009;7:90-6.
  15. Moon JM, Chun BJ, Lee BK. Glasgow coma scale score in the prognosis of acute carbamate insecitide intoxication. Clin Toxicol 2012;50:832-7.
  16. Ha SO, Park SH, Hong SB, Jang S. Performance evaluation of five different disseminated intravascular coagulation diagnostic criteria for predicting mortality in patients with complicated sepsis. J Korean Med Sci 2016;31:1838-45. https://doi.org/10.3346/jkms.2016.31.11.1838
  17. Sitprija V, Gopalakrishnakone P. Snake bite, rhabdomyolysis, and renal failure. Am J Kidney Dis. 1998;31(6):l-lii.
  18. Kularatne SAM, Hettiarachchi R, Dalpathadu J, Mendis ASV, Appuhamy PDSAN, Zoysa HDJ, et al. Enhydrina schistosa (Elapidae: Hydrophiinae) the most dangerous sea snake in Sri-Lanka: three case studies of severe envenoming. Toxicon 2014;77:78-86. https://doi.org/10.1016/j.toxicon.2013.10.031
  19. Johnston CI, Tasoulis T, Isbister GK. Australian Sea Snake Envenoming Causes Myotoxicity and Non-Specific Systemic Symptoms - Australian Snakebite Project (ASP-24). Front Pharmacol 2002;13:816795.
  20. Vangstad M, Bjornaas MA, Jacobsen D. Rhabdmolyolysis : a 10-year retrospective study of paitents treated in a medical department. Eur J Emerg Med 2019;26:199-204. https://doi.org/10.1097/MEJ.0000000000000510
  21. De Meijer AR, Fikkers BG, de Keijzer MH, Van Engelen BGM, Drenth JPH. Serum creatine kinase as predictor of clinical course in rhabdomyolysis: a 5-year intensive care survey. Intensive Care Med 2003; 29:1121-5.
  22. Cabral BMI, Edding SN, Portocarrero JP, Lerma EV. Rhabdomyolysis. dis Mon. 2020;66(8):101015.
  23. Brochard L, Abroug F, Brenner M, Broccard AF, Danner RL, Ferrer M, et al. An Official ATS/ERS/ESICM/SCCM/SRLF Statement: prevention and management of acute renal failure in the ICU patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med 2010;181:1128-55. https://doi.org/10.1164/rccm.200711-1664ST
  24. Matsumura M, Sato T. Rhabdomyolysis and acute renal failure after poisonous snake (Agkistrodon halys blomhoffii) bite. Intern Med 2001;40(6):551.
  25. Lane R, Phillips M. Rhabdomyolysis. BMJ 2003;327(7407);115-6. https://doi.org/10.1136/bmj.327.7407.115
  26. Bagley WH, Yang H, Shah KH. Rhabdomyolysis. Intern Emerg Med 2007;2(3):210-8. https://doi.org/10.1007/s11739-007-0060-8
  27. Geng Y, Ma Q, Du YS, Peng N, Yang T, Zhang SY, et al. Rhabdomyolysis is associated with in hospital mortality in patients with covid-19. Shock 2021;56(3):360-7. https://doi.org/10.1097/SHK.0000000000001725